Thirdly, with recombinant IL-22 proteins at present being explored as potential therapeutic strategies in human diseases as severe alcoholic hepatitis, graft-versus-host disease and inflammatory bowel disease, our research may have momentous clinical significances 18-19, 37. Here, IL22 is linked to inflammatory bowel disease.